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Background: Long interspersed element type one (L1) actively modifies the human genome by inserting new
copies of itself. This process, termed retrotransposition, requires the formation of an L1 ribonucleoprotein (RNP)
complex, which must enter the nucleus before retrotransposition can proceed. Thus, the nuclear import of L1 RNP
presents an opportunity for cells to regulate L1 retrotransposition post-translationally. The effect of cell division on
L1 retrotransposition has been investigated by two previous studies, which observed varied degrees of inhibition in
retrotransposition when primary cell strains or cancer cell lines were experimentally arrested in different stages of
the cell cycle. However, seemingly divergent conclusions were reached. The role of cell division on
retrotransposition remains highly debated.
Findings: To monitor both L1 expression and retrotransposition quantitatively, we developed a stable dual-
luciferase L1 reporter cell line, in which a bi-directional tetracycline-inducible promoter drives the expression of
both a firefly luciferase-tagged L1 element and a Renilla luciferase, the latter indicative of the level of promoter
induction. We observed an additional 10-fold reduction in retrotransposition in cell-cycle arrested cells even after
retrotransposition had been normalized to Renilla luciferase or L1 ORF1 protein levels. In synchronized cells, cells
undergoing two mitoses showed 2.6-fold higher retrotransposition than those undergoing one mitosis although L1
expression was induced for the same amount of time.
Conclusions: Our data provide additional support for an important role of cell division in retrotransposition and
argue that restricting the accessibility of L1 RNP to nuclear DNA could be a post-translational regulatory mechanism
for retrotransposition.
Keywords: Cell-cycle arrest, Cell-cycle synchronization, Cell division, Dual-luciferase assay, LINE-1, Non-LTR
retrotransposon, Nuclear import, Tetracycline-inducible promoter, Transcription, Stable cell lineFindings
Long interspersed elements type one (LINE-1; L1), the
only active autonomous transposable element in the hu-
man genome, have played a major role in human genome
evolution and are also responsible for an increasing num-
ber of sporadic human genetic diseases [1-3]. To make
new copies, a source L1 element must successfully navi-
gate through every stage of the retrotransposition process
(that is, transcription, translation, and target-primed
reverse transcription). An essential intermediate step is
the formation of an L1 ribonucleoprotein (RNP) complex
between L1 mRNA and proteins [4-6]. L1 RNP must enter* Correspondence: wenfengan@vetmed.wsu.edu
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reproduction in any medium, provided the orthe nucleus before a new copy is made via target-primed
reverse transcription [7]. Therefore, the nuclear import of
L1 RNP presents an opportunity for cells to regulate L1
retrotransposition post-translationally. As nuclear import
can occur passively when nuclear envelope breaks down
during cell division, the efficiency of retrotransposition is
predicted to be higher in actively dividing cells. Indeed,
the effect of cell division has been investigated by two
previous studies, which compared the level of L1
retrotransposition in cell-cycle arrested primary cell
strains and cancer cell lines [8,9]. Although both observed
varied degrees of inhibition in retrotransposition when
cells were experimentally arrested in different stages of
the cell cycle, one study concluded that cell division was
required for retrotransposition and the other determined
that L1 retrotransposition could occur in non-dividing. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 A comparison of the methods and findings from three studies
Kubo et al. [8] Shi et al. [9] This study
L1 vector Embedded in a helper-dependent
adenovirus
Episomal plasmid Embedded in an SB DNA transposon
(1) Promoter Mouse phosphoglycerate kinase-1 A native human L1 promoter
(50UTR)
Bi-directional tetracycline-inducible
promoter
(2) ORFs Human L1 RP Human L1 LRE3 Synthetic mouse L1 ORFeus
(3) Reporter EGFP EGFP Fluc
Gene delivery Adenoviral transduction Transient transfection with
nucleofector
Stably integrated by SB100X
L1 expression detection Co-expressed β-gal L1 RNA (RT-PCR) Co-expressed Rluc; L1 ORF1p
Cells for cell-cycle arrest assay Human glioma (Gli36) Human fetal lung fibroblast
(IMR-90); human cervical
carcinoma (HeLa)
HeLa Tet-ORFeus stable cell line
Cell-cycle arrest experiments and
observed effects on
retrotransposition
(i) G0 arrest ➜ complete inhibitiona; (i) G1, S, G2, or M arrest ➜
strong inhibitionc
(i) S, or S+G2/M arrest ➜ strong
inhibition;
(ii) G1/S arrest ➜ partial inhibitionb (ii) Cell-cycle synchronized cells
➜reduced retrotransposition if cells
divided one fewer cycle
Conclusion(s) regarding to the role
of cell division
L1 retrotransposition can occur in
non-dividing cells
Cell division is required for L1
retrotransposition; L1
transcription is the limiting
step
Cell division promotes efficient L1
retrotransposition; the inhibitory
effect of cell-cycle arrest on
retrotransposition cannot be
explained by reduced L1
transcription alone
Role of active nuclear import L1 RNP can be actively imported
into the nucleus
Not discussed An active nuclear import mechanism
is a possible explanation for residual
retrotransposition in cell-cycle
arrested cells
aCompared with cells resuming cycling, G0 arrested Gli36 cells showed a 16-fold reduction in the fraction of GFP-positive cells (54-fold if normalized to
co-expressed β-gal; see Figure five B in ref [8]).
bCompared with cycling cells, G1/S arrested Gli36 cells showed a three-fold reduction in the fraction of
GFP-positive cells (six-fold if normalized to co-expressed β-gal; see Figure four A in ref [8]).
cFold reduction in retrotransposition was not stated in the main text; up to 40-fold inhibition in retrotransposition could be discerned from raw data (see Figure
four A and B in ref [9]; data were not normalized to L1 RNA levels, which were reduced by approximately 10- to 20-fold in most conditions (see Figure five B in ref
[9]). However, the dynamic range of observed L1 retrotransposition activity (from 0 to 40 GFP-positive cells per 10,000 cells analyzed by flow cytometry) does not
allow the authors to discern additional layers of regulation for retrotransposition.
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transposition remains highly debated to date.
Development of a stable HeLa Tet-ORFeus cell line
To investigate the effect of cell-cycle arrest on L1 retro-
transposition, we wished to establish an assay system that
meets the following criteria: (1) It must be a stable cell line
with an integrated L1 reporter. Having an integrated L1
reporter eliminates variation in transfection efficiency that
is inherent in transient assays. However, this requirement
necessitates the use of an inducible promoter because,
otherwise, L1 insertions will accumulate while the cell line
is being established. (2) The promoter activity (that is,
transcription) can be conveniently monitored in parallel
to L1 retrotransposition. (3) Both the promoter activity
and L1 retrotransposition can be measured with high
sensitivity and in a wide dynamic range. Accordingly, we
designed an inducible dual-luciferase L1 assay vector,
pYX056 (Figure 1A; detailed in Additional file 1). The
design combined a gene regulation and a gene deliverysystem. First, the Tet-Off Advanced Inducible Gene Ex-
pression System allows stringent control of L1 expression.
The bi-directional PTight inducible promoter drives ex-
pression of Renilla luciferase (Rluc) and a hyperactive syn-
thetic mouse L1, ORFeus [10]. The latter is tagged with a
firefly luciferase/antisense intron (FlucAI) reporter cas-
sette [11]. The bi-directional PTight promoter consists of a
modified tetracycline-responsive element flanked by two
minimal CMV promoters. In the presence of doxycycline,
the tetracycline-controlled transactivator advanced (tTA)
is complexed with doxycycline and is unable to activate
PTight. Upon doxycycline withdrawal, free tTA will bind to
PTight and activate both L1 and Rluc transcription. Second,
the non-viral two-component Sleeping Beauty (SB) system
enables stable gene delivery. The L1/Rluc bi-directional
expression cassette is flanked by a pair of inverted ter-
minal repeats from SB, and can be ‘cut and pasted’ into
the genome by a hyperactive SB transposase (SB100X)
[12] (Figure 1B). Single cell clones were acquired by limit-
ing dilution method and screened for the lack of Rluc
Figure 1 L1 retrotransposition in a HeLa Tet-ORFeus stable cell line. (A) A schematic of the bi-directional inducible L1 construct. The bi-
directional tet-responsive promoter PTight drives the expression of an upstream Rluc cassette and a downstream L1 cassette. The L1 cassette
features coding sequences (that is, ORF1 and ORF2) from the synthetic L1 ORFeus and an antisense-stranded FlucAI reporter cassette [11]. In the
presence of doxycycline, PTight is inactive. FlucAI can be transcribed from its own SV40 promoter. However, no Fluc activity is expected because
Fluc coding sequence is interrupted by an antisense intron (sense relative to the L1 cassette). (B) Incorporation of the L1 construct into HeLa-tTA
cells. The L1 construct is terminally flanked by ITRs of the Sleeping Beauty DNA transposon (see panel A). To make a stable cell line, the L1
construct was co-transfected with SB100X into HeLa-tTA cells. Single cell clones were established through limiting dilution in the presence of
doxycycline. Rluc and Fluc were measured after doxycycline withdrawal. (C) The rationale of L1 retrotransposition assay with Tet-ORFeus cells. In
the absence of doxycycline, PTight is bound by tTA and activates the transcription of a Rluc mRNA and an L1 pre-mRNA. The intron is removed
from L1 pre-mRNA through splicing. The mature L1 mRNA is reverse transcribed and integrated into the genome (shown as a 50 truncated
insertion), forming a functional Fluc cassette.
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levels of Rluc expression upon doxycycline withdrawal
(Figure 1C; detailed in Additional file 1).
Control of L1 retrotransposition in HeLa Tet-ORFeus cells
by doxycycline
To characterize L1 retrotransposition in HeLa Tet-ORFeus
cells, we first tested the dose response by seeding cells in
different concentrations of doxycycline. Both Fluc andRluc signals were doxycycline dose-dependent (Additional
file 2). Significant Fluc signals were first observed after 30 h
incubation in doxycycline-free medium and subsequently
increased exponentially to 460-fold above background after
48 h incubation (P <0.01; Figure 2A). The rapid induction
of the PTight promoter via doxycycline withdrawal was
demonstrated by continued increase of Rluc signals from
three-fold (at 6 h) to 280-fold (at 48 h) above background
(P <0.01; Figure 2A). To directly measure L1 expression,
Figure 2 (See legend on next page.)
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Figure 2 The time course of L1 retrotransposition in HeLa Tet-ORFeus cells. (A) Fluc and Rluc activities from cell lysates. Cells were seeded
in 96-well plates (for luminescence) or 60 mm dishes (for protein and gDNA analyses) in the absence of doxycycline and harvested at the
indicated time points. Error bars represent mean±SE (n = 6). All readings were compared with the 0 h control (**P <0.01). (B) Time-dependent
increase of ORF1p expression. ORF1p and β-actin were detected by western blot. Murine embryonal carcinoma cells (F9) were used as a positive
control for ORF1p. The parental HeLa-tTA cells and uninduced HeLa Tet-ORFeus cells were used as negative controls. (C) Confirmation of L1
retrotransposition by end-point PCR. Genomic DNA was amplified by an intron-flanking primer pair. The presence of a band of 250 bp is
diagnostic for intron removal; the intron-containing donor DNA is amplified as a band of 1150 bp. NTC, no template control. Dox+, gDNA from
cells cultured in the presence of doxycycline for 48 h. Fluc plasmids with or without the intron were used as controls. Molecular weight was
indicated by the 1 kb Plus DNA Ladder (Invitrogen). (D) Quantification of L1 insertions by qPCR. The number of L1 insertions in gDNA was
determined by a TaqMan-based qPCR assay. qPCR signals were normalized by setting signals from the 48 h time point to 1. The normalized
signals from each time point were then compared with the 0 h time point by two-tailed Student’s t-test. P values are indicated (**P <0.01). Error
bars represent mean±SE (n = 3).
Xie et al. Mobile DNA 2013, 4:10 Page 5 of 10
http://www.mobilednajournal.com/content/4/1/10we quantified L1 ORF1 protein (ORF1p) by western blot
(Figure 2B). L1 ORF1p signals were first observed at 9 h,
peaked at 24 h, and subsequently maintained for the dur-
ation of the experiment (Figure 2B). Induction of Rluc or
ORF1p was not observed in HeLa Tet-ORFeus cells cul-
tured in 100 ng/mL of doxycycline, indicating PTight was
completely suppressed. Indeed, cells maintained under 100
ng/mL of doxycycline showed no accumulation of Fluc-
positive cells over 10 passages but could be robustly in-
duced upon doxycycline withdrawal (Additional file 3). To
confirm that Fluc signals were due to retrotransposition, we
monitored intron removal by genomic DNA PCR as previ-
ously described [11]. Consistent with Fluc measurement,
the intronless amplicon became most prominent at 30–48
h although weak amplicons could be observed in earlier
time points. As a control, no intronless band was seen in
HeLa Tet-ORFeus cells under 100 ng/mL of doxycycline
(Figure 2C). Similar to the transient dual-luciferase assays
[11], retrotransposition was inhibited by a nucleoside re-
verse transcriptase inhibitor in a dose-dependent manner
(Additional file 4). The number of L1 insertions was fur-
ther quantified by a quantitative PCR (qPCR) method as
previously described [13]. Similar to transient transfection
experiments [11], statistically significant signals were first
detected at 24 h (normalized activity = 5.6%, P <0.01)
(Figure 2D). It should be noted that, as opposed to anti-
biotic or fluorescent protein reporters, which can be used
to track individual retrotransposition events, the HeLa
Tet-ORFeus system measures retrotransposition from a
population of cells.
Cell-cycle arrest inhibits L1 retrotransposition
To test the effect of cell-cycle arrest in HeLa Tet-ORFeus
cells, cells were treated with three different inhibitors in the
absence of doxycycline. Cell-cycle analysis showed that cells
were arrested in S phase by aphidicolin and hydroxyurea
and in S+G2/M phase by thymidine (Figure 3A). The pres-
ence or absence of doxycycline had no effect on cell-cycle
status (compare Dox+ with Dox- in Figure 3A). As com-
pared with control cycling cells (that is, Dox-), arrested cells
showed 7.6% to 9.4% Rluc expression, indicating PTight wassuppressed in the arrested cells (Figure 3B; P <0.001,
detailed in Additional file 5: panel A). Indeed, western blot
analyses confirmed that, as compared with the Dox- group,
the level of ORF1p was reduced to 6% to 15% in the
arrested cells (Figure 3C). If the frequency of retro-
transposition was a simple function of L1 expression, we
would expect a proportional reduction of retrotransposition
in arrested cells (that is, approximately 10% of cycling cells).
However, the Fluc signal in arrested cells was at most 0.8%
of the Dox- group (Figure 3B; P <0.001, detailed in
Additional file 5: panel B), indicating the presence of an
additional approximate 10-fold reduction in retrotrans-
position that cannot be explained by the decrease in L1 ex-
pression. A potential caveat for these results is that the
level of retrotransposition was indirectly measured by the
expression of Fluc from integrated L1 insertions; this may
cause an ascertainment bias between control and treatment
groups if the inhibitors affect Fluc expression. Thus, we
directly quantified retrotransposition by qPCR, a method
that is independent of Fluc expression. Results from these
qPCR experiments confirmed the additional reduction in
retrotransposition in cell-cycle arrested cells (Figure 3D): in
all three treatment groups, the magnitude of decease in
qPCR signal was greater than the fold reduction in L1 ex-
pression, regardless whether L1 expression is measured as
Rluc or ORF1p. On the other hand, two out of the three in-
hibitors displayed an inhibitory effect on Fluc expression
when the Fluc data and qPCR data were compared (0.09%
versus 0.4% for hydroxyurea treated cells and 0.8% versus
3.8% for thymidine treated cells, respectively; compare
Figure 3B and 3D). As a result, we compared the correl-
ation between ORF1p and qPCR data. After adjusting the
decrease in ORF1p, qPCR showed additional 8.7-, 27.5-,
and four-fold reductions in retrotransposition in aphidi-
colin, hydroxyurea, and thymidine treated cells, respectively
(compare Figure 3C and 3D).
L1 retrotransposition in synchronized HeLa Tet-ORFeus cells
To exclude the possibility that the observed inhibition of
L1 retrotransposition is caused by unknown side effects
of inhibitors used, we wished to test the effect of cell
Figure 3 (See legend on next page.)
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Figure 3 Cell-cycle arrests inhibit L1 retrotransposition in HeLa Tet-ORFeus cells. (A) Cell-cycle analysis. HeLa Tet-ORFeus cells were
cultured in doxycycline-free medium (Dox-) or supplemented with 5 μg/mL aphidicolin, 75 μg/mL hydroxyurea, or 2 mM thymidine. Cells
cultured in 100 ng/mL doxycycline were used as control (Dox+). The distribution of cells in different phases of the cell cycle and their
corresponding DNA content histograms are shown. (B) Normalized Fluc and Rluc activities. HeLa Tet-ORFeus cells were treated as in panel A for
48 h. Raw luminescence readings were normalized by cell viability first and then to those from Dox- cells (Flucmean = 425,000 and Rlucmean =
314,000). Error bars represent mean±SE (n=6). Statistical analyses are presented in Additional file 5. (C) The effect of cell-cycle arrest on ORF1p
expression. Representative western blots were shown for ORF1p and β-actin; quantitative data were calculated from three biological replicates
and had been normalized by β-actin. F9 cells were used as a positive control for ORF1p. The parental HeLa-tTA cells and uninduced HeLa
Tet-ORFeus cells (Dox+) were used as negative controls. (D) Quantification of L1 insertions by qPCR. The number of L1 insertions in gDNA was
determined by a TaqMan-based qPCR assay. qPCR signals were normalized by setting signals from the Dox- cells to 1 (equivalent to 4.9 copies
per cell as estimated from plasmid DNA dilution series). Error bars represent mean±SE (n=3).
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end, we synchronized HeLa Tet-ORFeus cells by double-
thymidine block and then allowed cells to enter normal
cell cycling by removing thymidine from the culture
medium (Figure 4A). According to cell-cycle analysis,
these cells would complete two full cell cycles in 44 h
(Figure 4A; Additional file 6). We compared retrotrans-
position under two experimental conditions (b and d in
Figure 4A). L1 transcription was induced for the same
amount of time in both conditions (that is, 37 h). How-
ever, the withdrawal of doxycycline was timed so that L1
expression was activated at different cell-cycle phases.
As a result, when L1 expression was induced, cells in ex-
periment b would undergo G2/M phase once whereas
cells in experiment d would undergo G2/M phase twice
(Figure 4A). After 37 h induction, dual-luciferase read-
outs were taken from both conditions. Both showed
similar levels of promoter activities (Figure 4B) but the
level of retrotransposition was 2.6-fold higher in experi-
ment d than in experiment b (P <0.05; Figure 4C). In
control experiments, we demonstrated that the difference
in assay duration did not alter the assay background
(Figure 4A to C; conditions a and c, where cells were re-
leased from the double-thymidine block but remained in
doxycycline-supplemented medium). Thus, these data
from synchronized cells further support the conclusion
that cell division promotes L1 retrotransposition, and thus
is a potential means of regulating L1 activity.Figure 4 L1 retrotransposition in synchronized HeLa Tet-ORFeus cells
time 0. Cells were incubated in the presence (solid line) or absence (dotted
readouts. (C) Fluc readouts. Error bars represent mean±SE (n=6).In summary, our data provide additional support for
an important role of cell division in L1 retrotrans-
position and argue that restricting the accessibility of L1
RNP to nuclear DNA could be a post-translational regu-
latory mechanism for retrotransposition (Table 1). As
compared with the two previous studies [8,9], our ex-
perimental approach has several advantages for assessing
the role of cell division in retrotransposition. First, the
dual-luciferase system provided an efficient means of
simultaneous quantification of both L1 expression and
L1 retrotransposition. Second, the use of an inducible,
integrated reporter not only allowed us to avoid vari-
ation in gene transfer efficiency between experimental
conditions but also to better resemble the replication
cycle of endogenous L1 elements, which express from
chromosomal rather than episomal DNA. Indeed, it
allowed us to separate two layers of regulation in cell-
cycle arrested cells: one layer is at the transcriptional
level, which was highlighted by Shi et al. [9]; the other
layer is downstream and independent of L1 transcrip-
tion, as indicated by both Rluc signals and ORF1p levels
(discussed below). Lastly, our inducible system permitted
the comparison of retrotransposition in synchronized
cell populations where the major difference was the
number of mitoses completed.
Integrating our data and those of previous studies [8,9],
we propose that active cell division promotes retrotrans-
position. All three studies showed strong inhibition of. (A) Synchronized cells were released from double-thymidine block at
line) of doxycycline for varied time periods as indicated. (B) Rluc
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analyzed L1 RNA levels in their assay system and attrib-
uted the inhibitory effect on retrotransposition largely to
reduced L1 transcription (Table 1). The assay systems used
by this study and Kubo et al. [8] enabled retrotransposition
at larger dynamic ranges, permitting the evaluation of add-
itional layers of regulation. In this study, after Fluc signals
were normalized to the co-expressed Rluc, we observed an
additional 10-fold reduction in retrotransposition in cell-
cycle arrested HeLa Tet-ORFeus cells and a 2.6-fold reduc-
tion in synchronized cells undergoing one fewer round of
cell division. Thus, after factoring in the effect of drug
treatment on L1 expression, our data support an import-
ant role of cell division in promoting efficient L1 retro-
transposition in a manner independent of L1 expression. It
is noteworthy that, even when the variable infection rate
was not taken into consideration, Kubo et al. [8] found a
three-fold reduction of retrotransposition in G1/S arrested
cells in addition to a 16-fold reduction of retrotrans-
position in G0 arrested Gli36 cells (Table 1). On the other
hand, both Kubo et al. [8] and the current study showed
substantial retrotransposition in cell-cycle arrested cells
(for two of the three inhibitors tested, we observed statisti-
cally significant Fluc signals at approximately 10-fold
above the assay background). Currently, we cannot ex-
clude the possibility that the residual retrotransposition
observed in arrested cell populations in both studies origi-
nates from a minor population of cycling cells. An alterna-
tive explanation for such residual retrotransposition is that
L1 retrotransposition may also be facilitated by a yet
uncharacterized active nuclear import mechanism (Table 1).
Indeed, the control experiments performed by Kubo et al.
[8] in G1/S arrested cells, showing differential transduc-
tion by retroviral and lentiviral vectors, support the
presence of an active nuclear import mechanism for L1
retrotransposition. It is noteworthy that some non-LTR
(long terminal repeat) retrotransposons have evolved
active nuclear import strategies for their propagation in
respective host species. A precedent of active nuclear im-
port has been reported for the telomeric repeat-specific
SART1 retrotransposon from Bombyx mori: its ORF1p
contains functional nuclear localization signals (NLSs),
which are required for active retrotransposition [14]. Thus
far, no NLS has been reported in mammalian L1 proteins
although both ORF1 and ORF2 proteins have highly basic
regions, which is a common feature of nuclear localized
proteins. Alternatively, it is possible active nuclear import
is mediated by other host-derived components of L1 RNP.
Recently, two poly(A) binding proteins, PABPN1 and
PABPC1, were found to be associated with L1 RNP [15].
Of particular interest, PABC1 was found to be critical for
RNP formation; as it can shuttle between the cytoplasm
and the nucleus, it would be interesting to determine
whether PABPC1 mediates RNP nuclear import [15].A caveat shared by all three studies is that the role of
cell division in retrotransposition was mainly assessed in
cancerous cell lines (Table 1; but note Shi et al. [9] also
tested normal human fetal lung fibroblasts). Additionally,
two of these studies ([8] and the current study) used non-
native promoters to drive L1 expression (Table 1), which
precludes the study of the endogenous transcriptional
regulation of L1 with these systems. Nevertheless, a unify-
ing view from these and other studies of L1 variants, mu-
tations, and host factors ([15-19] and citations therein) is
that retrotransposition is not a simple function of L1 ex-
pression. By extension, the level of L1 expression cannot
be equated with the frequency of retrotransposition and
the evaluation of retrotransposition should take into con-
sideration the cell-cycle status. For example, in normal
individuals, endogenous L1 expression has only been con-
firmed at protein level in testicular and ovarian tissues
([20-22]; reviewed in [23]). It is noteworthy that L1 ORF1p
is detected in two distinct stages of male germ cell devel-
opment, namely, in gonocytes (embryonic stage) and in
meiotic/post-meiotic germ cells (prepuberal and through
adulthood) [20-22]. However, during both stages cell div-
ision is limited: gonocytes are mitotically arrested in G0
phase [24] while spermatocytes only divide twice before
becoming haploid spermatids. Similarly, in the female
germline, L1 ORF1p is detected during the meiotic pro-
phase I in embryonic oocytes [21], which are subsequently
arrested in the diplotene stage of the meiotic prophase I
and do not divide until puberty [25]. Therefore, both male
and female germline development may have been
programmed in a way that restricts excessive retrotrans-
position by avoiding frequent nuclear membrane break-
down when L1 is expressed. Thus, to understand the
developmental timing of retrotransposition, it is impera-
tive to measure the level of retrotransposition directly.
Additional files
Additional file 1: Materials and methods. Detailed description of
materials and methods used.
Additional file 2: Figure S1. Dose-dependent induction of L1
retrotransposition in HeLa Tet-ORFeus cells. HeLa Tet-ORFeus cells were
seeded in 96-well plate at 3,000 cells/well and cultured in the presence
of different concentrations of doxycycline. Fluc and Rluc were measured
after 48 h incubation. Error bars represent mean±SE (n=4). At high doses
in the range of 6.3 to 100 ng/mL, both Rluc and Fluc showed no
deviation from background readings. Retrotransposition, as indicated by
the Fluc signal, was detected in cells treated with lower doses of
doxycycline. In particular, retrotransposition reached 120-fold above
background under 0.8 ng/mL of doxycycline (P <0.001) and 3,600-fold
above background in doxycycline-free medium (P <0.001). As expected,
the level of retrotransposition was correlated with PTight promoter activity,
which was measured by Rluc. At 0.8 ng/mL of doxycycline, Rluc was
induced to five-fold above background (P <0.05); in doxycycline-free
medium, Rluc was induced to 620-fold above background (P <0.001). It
should be noted that Fluc signal had increased above background at 1.6
to 3.2 ng/mL concentrations while Rluc activity remained undetectable.
This discrepancy is likely due to the known higher sensitivity of Fluc than
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Tet-ORFeus cells could be induced by reducing or eliminating
doxycycline from the culture medium.
Additional file 3: Figure S2. Induction of L1 retrotransposition in HeLa
Tet-ORFeus cells after multiple passages. HeLa Tet-ORFeus cells were
maintained in the presence of 100 ng/mL doxycycline and passaged in
approximately every 3 days. Aliquots of cells from each of the 10
continuous passages (P0 to P9) were seeded in the presence (Dox+,
shown in panel A) or absence (Dox-, shown in panel B) of 100 ng/mL
doxycycline. Fluc and Rluc were measured 48 h after seeding. Note very
different scales are used for the two panels. Panel A shows that Fluc and
Rluc signals from uninduced cells are always below 1,000 relative light
units, which represent the assay background and are comparable to
readings from empty wells. Cells from most passages were seeded at the
density of 3,000 to 5,000 cells/well in 96-well plates. The only exception
was cells from P2, which were seeded at a much higher density (40,000
cells/well) in a 96-well plate; this suboptimal seeding density may explain
the much reduced Fluc and Rluc signals in P2 cells in the absence of
doxycycline (panel B). Error bars represent mean±SE (n=4 or 6). In
summary, for cells from all passages tested, Fluc and Rluc were
completely inhibited by doxycycline but were consistently induced upon
doxycycline withdrawal.
Additional file 4: Figure S3. Dose-dependent inhibition of L1
retrotransposition by 3TC in HeLa Tet-ORFeus cells. HeLa Tet-ORFeus cells
were seeded in a 96-well plate at 3,000 cells/well and cultured in the
presence of different concentrations of 20,30-dideoxy-30-thiacytidine (3TC;
0, 0.016, 0.08, 0.4, 2, or 10 μM) and with (Dox+) or without (Dox-) 100 ng/
mL doxycycline. Fluc signals were measured after 48 h incubation with
Promega ONE-Glo Luciferase Assay System. Error bars represent mean±SE
(n=8). Two-tailed Student’s t-test was used to compare Fluc signals from
3TC-treated cells to non-3TC-treated cells, respectively, for Dox+ and
Dox- conditions; resulting P values are indicated (**P <0.01, ***P <0.001).
Additional file 5: Figure S4. Effect of cell-cycle arrests on Rluc and Fluc
activities in HeLa Tet-ORFeus cells. The underlying data are the same as
in Figure 3B but Rluc and Fluc data are separately graphed to highlight
the difference among experimental conditions. Raw Rluc (panel A) and
Fluc (panel B) readings are shown underneath the x-axis labels. They
were normalized by cell viability first and then to those from Dox- cells
and plotted. Error bars represent mean±SE (n=6). Pairwise two-tailed
Student’s t-test was used to compare Rluc or Fluc signals between
treatment groups; resulting P values are indicated (*P <0.05, **P <0.01,
***P <0.001).
Additional file 6: Figure S5. Cell-cycle progression after HeLa Tet-
ORFeus cells released from double-thymidine block. HeLa Tet-ORFeus cells
were synchronized at G1/S phase and subsequently allowed to cycle by
incubating in complete medium in the absence of thymidine and
doxycycline. The time of release from thymidine block was designated as
time 0. Cells were collected every 4 h and subjected to cell-cycle analysis.
The distribution of cell-cycle phases (G1, S, and G2/M) was plotted over
time. The first column ‘C’ denotes a control population of unsynchronized
cells. Note cells progressed through the first full cycle (from S, G2/M, G1 to
the next S) within the first 20 h relatively synchronously but the second
cycle was not as synchronous as the first cycle.
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